US HB2058 | 2015-2016 | 114th Congress
Status
Spectrum: Partisan Bill (Republican 76-2)
Status: Introduced on April 28 2015 - 25% progression, died in committee
Action: 2015-05-01 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 28 2015 - 25% progression, died in committee
Action: 2015-05-01 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
FDA Deeming Authority Clarification Act of 2015 This bill amends the Federal Food, Drug, and Cosmetic Act to revise premarket review and reporting requirements for products deemed by the Food and Drug Administration (FDA) to be tobacco products. A product is not subject to premarket review by the FDA if it is introduced to market before that type of product is deemed a tobacco product. A person introducing a tobacco product that is substantially similar to a marketed product less than 21 months after that type of product is deemed a tobacco product must submit a report to the FDA on the similar product not later than 21 months after that type of product is deemed a tobacco product. (A report is required at least 90 days prior to introduction of a tobacco product that is substantially similar to a marketed product if that type of product has been deemed a tobacco product for 21 months or more.)
Title
FDA Deeming Authority Clarification Act of 2015
Sponsors
History
Date | Chamber | Action |
---|---|---|
2015-05-01 | House | Referred to the Subcommittee on Health. |
2015-04-28 | House | Referred to the House Committee on Energy and Commerce. |
2015-04-28 | House | Sponsor introductory remarks on measure. (CR E596) |
2015-04-28 | House | Introduced in House |
Subjects
Administrative law and regulatory procedures
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug, alcohol, tobacco use
Food and Drug Administration (FDA)
Health
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Drug, alcohol, tobacco use
Food and Drug Administration (FDA)
Health
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/114th-congress/house-bill/2058/all-info |
Text | https://www.congress.gov/114/bills/hr2058/BILLS-114hr2058ih.pdf |